Wednesday, 28 October 2026

Product News

Servier Laboratories (Ireland) Ltd announce that Lipertance will be available for prescription from November 2021

Lipertance® is the first Statin + ACEi + Calcium Channel blocker combination available in Ireland.

By Danielle Norton Updated 2 min read
Blank Box Small

Servier Laboratories (Ireland) Ltd is delighted to announce that Lipertance, the combination of atorvastatin, perindopril and amlodipine1, will be available for prescription from November 2021 and is listed as a PCRS reimbursable product.

Lipertance® is the first Statin + ACEi + Calcium Channel blocker combination available in Ireland2.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Related stories

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free